Acomplia (Rimonabant) is an obesity treatment developed by French pharmaceutical giant Sanofi – Aventis. Rimonabant, active ingredient in Acomplia, came out of knowledge that cannabis smokers often experience extreme hunger sensations. Scientists from Sanofi – Aventis used this fact and developed a revolutionary drug, a first one of its kind on the market today.
Acomplia (Rimonabant) acts directly on central cannabinoid (CB1) receptors. CB1 receptors are believed to play a role in controlling food consumption and the phenomena of dependence. When Acomplia (Rimonabant) is ingested CB1 receptors are blocked form receiving signals and the feeling of hunger is suppressed. Rimonabant is the first CB1 suppressant approved by regulatory commissions for human consumption.
Beside from being appetite suppressant, Acomplia is also helping in treating dependence. This is the first drug being used as smoking cessation treatment. Also recent studies have proven beneficial effects Acomplia has on human cardiovascular metabolic system.
Rimonabants efficiency and safety has been proven in several long term studies and clinical trials. Daly dose of 20mg of Acomplia has been shown to prevent weight gain in clinical study patients for up to two years.
All documented side effects have been short term and have diminished within two weeks. Side effects are mild and mostly negligible. They might include dizziness, nausea, stomach upset, muscle cramp, diarrhea, sleep disorders amongst others and all of them are temporary. If side effects do not seize after or if they become more persist over an extended span of time, seek immediate medical help. Acomplia (Rimonabant) has been approved by European Commission for sale in all 27 EU member countries since 2006.
Before you start with Acomplia (Rimonabant), prior conversation with your physician is suggested to prevent any future harmful repercussions. Inform your doctor of any other medication or supplement you are currently using to prevent contraindications. Pregnant women and nursing mothers should not be using Acomplia (Rimonabant). Seek immediate medical attention, if you undergo any side effects for an extended period of time.